ANNIE KUEHNEL: Open Payments
NPI 1326263351 · PEMBROKE PINES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,707 in 190 payments from 40 companies in 2025. Trend: 2023 $1,280 · 2024 $2,324 · 2025 $3,707
Food & beverage: $3,515Education: $192
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 13 | $317 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $250 |
| Novartis Pharmaceuticals Corporation | 19 | $238 |
| TerSera Therapeutics LLC | 9 | $225 |
| PFIZER INC. | 10 | $208 |
| Janssen Biotech, Inc. | 10 | $196 |
| AstraZeneca Pharmaceuticals LP | 9 | $184 |
| Astellas Pharma US Inc | 4 | $167 |
| GENZYME CORPORATION | 10 | $165 |
| Eisai Inc. | 17 | $150 |
Products named: Enhertu, Zoladex, Lenvima, TALVEY, DATROWAY, ZIIHERA, Fabhalta, MONJUVI.
Industry payments across FL — which companies pay providers there.
